Air Transport Services Group is a holding company. Through its subsidiaries, the company owns and leases aircraft to external customers and its airline subsidiaries. The company's services include: Aircraft Leasing, which owns and leases aircraft through its subsidiary Cargo Aircraft Management, Inc.; Airline Operations, which provides various combinations of aircraft, crews, maintenance and insurance to provide customized transportation capacity through its subsidiaries, ABX Air, Inc., Air Transport International, Inc. and Omni Air International, LLC; and Support Services, which provides air transportation related services including aircraft maintenance and modification, ground handling and crew training.

Atrion develops and manufactures products, primarily for medical applications. The company's fluid delivery products include valves designed to fill, hold and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter and other applications. The company's primary cardiovascular products is the MPS2? Myocardial Protection System, which is used in open-heart surgery that delivers to the heart essential fluids and medications, mixes critical drugs and controls temperature, pressure and other variables. The company also manufactures medical devices that disinfect contact lenses and balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Blueprint Medicines is a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy. The company has one precision therapy approved by the United States Food and Drug Administration, and is developing investigational medicines in clinical development, along with various research programs including: Avapritinib, which is for the treatment of systemic mastocytosis (SM); BLU-263, which is for the treatment of indolent SM and other mast cell disorders; pralsetinib, which is for the treatment of RET-altered non-small cell lung cancer, medullary thyroid carcinoma, and other solid tumors; and fisogatinib, which is for the treatment of hepatocellular carcinoma.

Eagle Pharmaceuticals is a pharmaceutical company focused on developing and commercializing injectable products, mainly in the critical care and oncology areas, using the U.S. Food and Drug Administration's (FDA's) 505(b)(2) New Drug Application regulatory pathway. The company's product portfolio includes four products: Argatroban, an anti-coagulant, thrombin inhibitor for heparin-induced thrombocytopenia; Ryanodex, a muscle relaxant for malignant hyperthermia; Belrapzo; and Bendeka. The company also has advanced product candidates which include EP-4104 (dantrolene sodium for exertional heat stroke), EP-5101 (PEMFEXY?), a pemetrexed injection ready-to-dilute formulation and EGL-5385-C-1701 (fulvestrant).

Enanta Pharmaceuticals is a biotechnology company that creates small molecule drugs primarily for the treatment of viral infections and liver diseases. The company's wholly owned research and development programs are in virology, namely respiratory syncytial virus and hepatitis B virus, and in liver disease (non-virology), namely non-alcoholic steatohepatitis and primary biliary cholangitis. Through its Collaborative Development and License Agreement with AbbVie Inc (AbbVie), the company has discovered and out-licensed to AbbVie two protease inhibitor compounds that have been clinically tested, manufactured, and commercialized by AbbVie for the treatment of hepatitis C virus.

Everbridge is a software company that provides enterprise software applications that automate and accelerate organizations' operational response to events in order to keep people safe and businesses running. Through its Critical Event Management platform, the company delivers applications that provide organizations with the ability to assess threats, locate people, automate actions, monitor incident response, and deliver contextual communications in any volume, in near-real time. The company's applications include mass notification, safety connection, incident management, information technology alerting, visual command center, public warning, community engagement , crisis management, and secure messaging.

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in immunology, inflammation and oncology. The company has four clinical-stage product candidates: GB001 (Prostaglandin D2 receptor 2 Antagonist), which is for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions; GB002 (Platelet-derived growth factor Receptor Kinase Inhibitor), which is for the treatment of pulmonary arterial hypertension; GB004 (Hypoxia inducible factor-1a Stabilizer), which is for the treatment of inflammatory bowel disease; and GB1275 (CD11b Modulator), which is for the treatment of oncology indications.

National Research is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations. The company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations across a range of elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management and brand loyalty. The company partners with clients across the continuum of healthcare services. The company's clients include integrated health systems, post-acute providers and payer organizations.

Qiagen is provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. Co.'s sample technologies process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software interprets data. Automation solutions unite these together in molecular testing workflows. Co. provides these workflows to four classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Co. markets its products in more than 130 countries.

Splunk provides software solutions that enable users to investigate, monitor, analyze and act on machine data. The company's main product is Splunk Enterprise, a machine data platform, comprised of collection, indexing, search, reporting, analysis, alerting, monitoring and data management capabilities. The company's Splunk Cloud delivers the capabilities of Splunk Enterprise as a service, while Splunk Light provides log search and analysis for information technology environments. The company also provides services that include maintenance and customer support, training services to its customers and channel partners, as well as consulting and implementation services to customers through its services team.